Skip to main content
Top
Published in: BMC Medicine 1/2018

Open Access 01-12-2018 | Research article

Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany – a mathematical modelling study

Authors: Johannes Horn, Oliver Damm, Wolfgang Greiner, Hartmut Hengel, Mirjam E. Kretzschmar, Anette Siedler, Bernhard Ultsch, Felix Weidemann, Ole Wichmann, André Karch, Rafael T. Mikolajczyk

Published in: BMC Medicine | Issue 1/2018

Login to get access

Abstract

Background

Epidemiological studies suggest that reduced exposure to varicella might lead to an increased risk for herpes zoster (HZ). Reduction of exposure to varicella is a consequence of varicella vaccination but also of demographic changes. We analyzed how the combination of vaccination programs and demographic dynamics will affect the epidemiology of varicella and HZ in Germany over the next 50 years.

Methods

We used a deterministic dynamic compartmental model to assess the impact of different varicella and HZ vaccination strategies on varicella and HZ epidemiology in three demographic scenarios, namely the projected population for Germany, the projected population additionally accounting for increased immigration as observed in 2015/2016, and a stationary population.

Results

Projected demographic changes alone result in an increase of annual HZ cases by 18.3% and a decrease of varicella cases by 45.7% between 1990 and 2060. Independently of the demographic scenario, varicella vaccination reduces the cumulative number of varicella cases until 2060 by approximately 70%, but also increases HZ cases by 10%. Unlike the currently licensed live attenuated HZ vaccine, the new subunit vaccine candidate might completely counteract this effect. Relative vaccine effects were consistent across all demographic scenarios.

Conclusion

Demographic dynamics will be a major determinant of HZ epidemiology in the next 50 years. While stationary population models are appropriate for assessing vaccination impact, models incorporating realistic population structures allow a direct comparison to surveillance data and can thus provide additional input for immunization decision-making and resource planning.
Appendix
Available only for authorised users
Literature
1.
go back to reference Murray CJ, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, Dansereau EA, Graetz N, Barber RM, Brown JC, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):1005–70.CrossRefPubMedPubMedCentral Murray CJ, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, Dansereau EA, Graetz N, Barber RM, Brown JC, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):1005–70.CrossRefPubMedPubMedCentral
2.
go back to reference Peters E, Pritzkuleit R, Beske F, Katalinic A. Demographic change and disease rates: a projection until 2050. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010;53(5):417–26.CrossRefPubMed Peters E, Pritzkuleit R, Beske F, Katalinic A. Demographic change and disease rates: a projection until 2050. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010;53(5):417–26.CrossRefPubMed
3.
go back to reference Chongsuvivatwong V, Phua KH, Yap MT, Pocock NS, Hashim JH, Chhem R, Wilopo SA, Lopez AD. Health and health-care systems in southeast Asia: diversity and transitions. Lancet. 2011;377(9763):429–37.CrossRefPubMed Chongsuvivatwong V, Phua KH, Yap MT, Pocock NS, Hashim JH, Chhem R, Wilopo SA, Lopez AD. Health and health-care systems in southeast Asia: diversity and transitions. Lancet. 2011;377(9763):429–37.CrossRefPubMed
4.
go back to reference Ajelli M, Merler S, Fumanelli L, Bella A, Rizzo C. Estimating measles transmission potential in Italy over the period 2010-2011. Ann Ist Super Sanita. 2014;50(4):351–6.PubMed Ajelli M, Merler S, Fumanelli L, Bella A, Rizzo C. Estimating measles transmission potential in Italy over the period 2010-2011. Ann Ist Super Sanita. 2014;50(4):351–6.PubMed
5.
go back to reference Marziano V, Poletti P, Guzzetta G, Ajelli M, Manfredi P, Merler S. The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study. Proc Biol Sci. 2015;282(1804):20142509.CrossRefPubMedPubMedCentral Marziano V, Poletti P, Guzzetta G, Ajelli M, Manfredi P, Merler S. The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study. Proc Biol Sci. 2015;282(1804):20142509.CrossRefPubMedPubMedCentral
6.
go back to reference Manfredi P, Williams JR. Realistic population dynamics in epidemiological models: the impact of population decline on the dynamics of childhood infectious diseases. Measles in Italy as an example. Math Biosci. 2004;192(2):153–75.CrossRefPubMed Manfredi P, Williams JR. Realistic population dynamics in epidemiological models: the impact of population decline on the dynamics of childhood infectious diseases. Measles in Italy as an example. Math Biosci. 2004;192(2):153–75.CrossRefPubMed
7.
go back to reference Williams JR, Manfredi P. Ageing populations and childhood infections: the potential impact on epidemic patterns and morbidity. Int J Epidemiol. 2004;33(3):566–72.CrossRefPubMed Williams JR, Manfredi P. Ageing populations and childhood infections: the potential impact on epidemic patterns and morbidity. Int J Epidemiol. 2004;33(3):566–72.CrossRefPubMed
8.
go back to reference Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wichmann O. Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis. 2011;11:173.CrossRefPubMedPubMedCentral Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wichmann O. Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis. 2011;11:173.CrossRefPubMedPubMedCentral
9.
go back to reference Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002;20(19-20):2500–7.CrossRefPubMed Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002;20(19-20):2500–7.CrossRefPubMed
10.
go back to reference Ogunjimi B, Van Damme P, Beutels P. Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review. PLoS One. 2013;8(6):e66485.CrossRefPubMedPubMedCentral Ogunjimi B, Van Damme P, Beutels P. Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review. PLoS One. 2013;8(6):e66485.CrossRefPubMedPubMedCentral
11.
go back to reference Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000;125(3):651–69.CrossRefPubMedPubMedCentral Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000;125(3):651–69.CrossRefPubMedPubMedCentral
12.
go back to reference van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine. 2011;29(13):2411–20.CrossRefPubMed van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine. 2011;29(13):2411–20.CrossRefPubMed
13.
go back to reference Karhunen M, Leino T, Salo H, Davidkin I, Kilpi T, Auranen K. Modelling the impact of varicella vaccination on varicella and zoster. Epidemiol Infect. 2010;138(4):469–81.CrossRefPubMed Karhunen M, Leino T, Salo H, Davidkin I, Kilpi T, Auranen K. Modelling the impact of varicella vaccination on varicella and zoster. Epidemiol Infect. 2010;138(4):469–81.CrossRefPubMed
14.
go back to reference Guzzetta G, Poletti P, Del Fava E, Ajelli M, Scalia Tomba GP, Merler S, Manfredi P. Hope-Simpson’s progressive immunity hypothesis as a possible explanation for herpes zoster incidence data. Am J Epidemiol. 2013;177(10):1134–42.CrossRefPubMed Guzzetta G, Poletti P, Del Fava E, Ajelli M, Scalia Tomba GP, Merler S, Manfredi P. Hope-Simpson’s progressive immunity hypothesis as a possible explanation for herpes zoster incidence data. Am J Epidemiol. 2013;177(10):1134–42.CrossRefPubMed
15.
go back to reference Bilcke J, Ogunjimi B, Hulstaert F, Van Damme P, Hens N, Beutels P. Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice? Vaccine. 2012;30(17):2795–800.CrossRefPubMed Bilcke J, Ogunjimi B, Hulstaert F, Van Damme P, Hens N, Beutels P. Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice? Vaccine. 2012;30(17):2795–800.CrossRefPubMed
16.
go back to reference Cook SJ, Flaherty DK. Review of the persistence of herpes zoster vaccine efficacy in clinical trials. Clin Ther. 2015;37(11):2388–97.CrossRefPubMed Cook SJ, Flaherty DK. Review of the persistence of herpes zoster vaccine efficacy in clinical trials. Clin Ther. 2015;37(11):2388–97.CrossRefPubMed
17.
go back to reference Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barbera J, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087–96.CrossRefPubMed Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barbera J, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087–96.CrossRefPubMed
18.
go back to reference Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Diez-Domingo J, Godeaux O, Levin MJ, McElhaney JE, Puig-Barbera J, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375(11):1019–32.CrossRefPubMed Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, Diez-Domingo J, Godeaux O, Levin MJ, McElhaney JE, Puig-Barbera J, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375(11):1019–32.CrossRefPubMed
19.
go back to reference Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Hengel H, Greiner W, et al. Current and future effects of varicella and herpes zoster vaccination in Germany - insights from a mathematical model in a country with universal varicella vaccination. Hum Vaccin Immunother. 2016;12(7):1766–76.PubMedPubMedCentral Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Hengel H, Greiner W, et al. Current and future effects of varicella and herpes zoster vaccination in Germany - insights from a mathematical model in a country with universal varicella vaccination. Hum Vaccin Immunother. 2016;12(7):1766–76.PubMedPubMedCentral
20.
go back to reference Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008;5(3):e74.CrossRefPubMedPubMedCentral Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008;5(3):e74.CrossRefPubMedPubMedCentral
21.
go back to reference Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271–84.CrossRefPubMed Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271–84.CrossRefPubMed
22.
go back to reference Oxman MN, Levin MJ, Shingles Prevention Study Group. Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis. 2008;197 Suppl 2:S228–36.CrossRefPubMedPubMedCentral Oxman MN, Levin MJ, Shingles Prevention Study Group. Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis. 2008;197 Suppl 2:S228–36.CrossRefPubMedPubMedCentral
23.
go back to reference Schmader KE, Levin MJ, Gnann Jr JW, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis. 2012;54(7):922–8.CrossRefPubMedPubMedCentral Schmader KE, Levin MJ, Gnann Jr JW, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis. 2012;54(7):922–8.CrossRefPubMedPubMedCentral
24.
go back to reference Baillot A, Toikkanen S, Monazahian M. Jahresbericht 2014/2015. Hannover: Niedersächsisches Landesgesundheitsamt; 2016. www.nlga.niedersachsen.de/download/106361/Jahresbericht_2014_2015.pdf. Baillot A, Toikkanen S, Monazahian M. Jahresbericht 2014/2015. Hannover: Niedersächsisches Landesgesundheitsamt; 2016. www.nlga.niedersachsen.de/download/106361/Jahresbericht_2014_2015.pdf.
25.
go back to reference Ultsch B, Damm O, Beutels P, Bilcke J, Bruggenjurgen B, Gerber-Grote A, Greiner W, Hanquet G, Hutubessy R, Jit M, et al. Methods for health economic evaluation of vaccines and immunization decision frameworks: a consensus framework from a European vaccine economics community. Pharmacoeconomics. 2016;34(3):227–44.CrossRefPubMed Ultsch B, Damm O, Beutels P, Bilcke J, Bruggenjurgen B, Gerber-Grote A, Greiner W, Hanquet G, Hutubessy R, Jit M, et al. Methods for health economic evaluation of vaccines and immunization decision frameworks: a consensus framework from a European vaccine economics community. Pharmacoeconomics. 2016;34(3):227–44.CrossRefPubMed
Metadata
Title
Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany – a mathematical modelling study
Authors
Johannes Horn
Oliver Damm
Wolfgang Greiner
Hartmut Hengel
Mirjam E. Kretzschmar
Anette Siedler
Bernhard Ultsch
Felix Weidemann
Ole Wichmann
André Karch
Rafael T. Mikolajczyk
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2018
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-017-0983-5

Other articles of this Issue 1/2018

BMC Medicine 1/2018 Go to the issue